EA201000296A1 - Новые соединения - Google Patents
Новые соединенияInfo
- Publication number
- EA201000296A1 EA201000296A1 EA201000296A EA201000296A EA201000296A1 EA 201000296 A1 EA201000296 A1 EA 201000296A1 EA 201000296 A EA201000296 A EA 201000296A EA 201000296 A EA201000296 A EA 201000296A EA 201000296 A1 EA201000296 A1 EA 201000296A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- preparation
- new connections
- salts
- diastereomers
- enantiomers
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/08—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pulmonology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Psychiatry (AREA)
- Otolaryngology (AREA)
- Communicable Diseases (AREA)
- Psychology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
В заявке описаны обладающие ценными свойствами соединения общей формулы (I)в которой А, В, D, Y, R, R, R, Rи Rимеют указанные в описании изобретения значения, их энантиомеры, их диастереомеры, их смеси и их соли, прежде всего их физиологически совместимые соли с органическими или неорганическими кислотами или основаниями, способ их получения, содержащие такие фармакологически активные соединения лекарственные средства, способ их приготовления и их применение.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP2007/058408 WO2008022945A1 (de) | 2006-08-19 | 2007-08-14 | Arylsulfonamide mit analgetischer wirkung |
PCT/EP2008/052157 WO2009021758A1 (de) | 2007-08-14 | 2008-02-21 | Arylsulfonamide mit analgetischer wirkung |
EP08102043A EP2025673A1 (de) | 2007-08-14 | 2008-02-26 | Arylsulfonamide mit analgetischer Wirkung |
PCT/EP2008/060562 WO2009021944A1 (de) | 2007-08-14 | 2008-08-12 | Neue verbindungen |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201000296A1 true EA201000296A1 (ru) | 2010-08-30 |
Family
ID=40589564
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201000296A EA201000296A1 (ru) | 2007-08-14 | 2008-08-12 | Новые соединения |
Country Status (21)
Country | Link |
---|---|
US (1) | US8394805B2 (ru) |
EP (1) | EP2188269B1 (ru) |
JP (1) | JP5250627B2 (ru) |
KR (1) | KR20100055469A (ru) |
CN (1) | CN101821245B (ru) |
AR (1) | AR068341A1 (ru) |
AU (2) | AU2008288431A1 (ru) |
BR (1) | BRPI0815181A2 (ru) |
CA (1) | CA2696261A1 (ru) |
CO (1) | CO6331335A2 (ru) |
EA (1) | EA201000296A1 (ru) |
EC (1) | ECSP109978A (ru) |
MA (1) | MA31613B1 (ru) |
MX (1) | MX2010001664A (ru) |
NZ (1) | NZ583815A (ru) |
PE (1) | PE20090593A1 (ru) |
TN (1) | TN2010000072A1 (ru) |
TW (1) | TW200911744A (ru) |
UY (1) | UY31287A1 (ru) |
WO (1) | WO2009021944A1 (ru) |
ZA (1) | ZA201008350B (ru) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102006039003A1 (de) * | 2006-08-19 | 2008-02-21 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Verbindungen |
US8394805B2 (en) | 2007-08-14 | 2013-03-12 | Boehringer Ingelheim International Gmbh | Compounds |
EP2025675A1 (de) | 2007-08-14 | 2009-02-18 | Boehringer Ingelheim International GmbH | Arylsulfonamide mit analgetischer Wirkung |
US20110046106A1 (en) * | 2008-02-06 | 2011-02-24 | Boehringer Ingelheim International Gmbh | Aryl sulfonamides as effective analgesics |
BRPI0914556A2 (pt) * | 2008-08-12 | 2015-08-04 | Boehringer Ingelheim Int | Processo para a preparação de compostos de piperazina substituídos por cicloalquila |
US8207335B2 (en) * | 2009-02-13 | 2012-06-26 | Boehringer Ingelheim International Gmbh | Process for making certain compounds having B1 antagonistic activity |
WO2012017027A1 (de) * | 2010-08-05 | 2012-02-09 | Boehringer Ingelheim International Gmbh | Säureadditionssalze des 2-[2-[[(4-methoxy-2,6-dimethylphenyl)sulfonyl]-(methyl)amino]ethoxy]-n-methyl-n-[3-(4-methylpiperazin-1-yl)cyclohexyl]acetamids und ihre verwendung als bradykinin-b1 rezeptor antagonisten |
WO2012022796A2 (de) | 2010-08-20 | 2012-02-23 | Boehringer Ingelheim International Gmbh | Neue kombinationen |
AR082890A1 (es) | 2010-09-03 | 2013-01-16 | Gruenenthal Gmbh | Derivados sustituidos de tetrahidropirrolopirazina |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3584341D1 (de) | 1984-08-24 | 1991-11-14 | Upjohn Co | Rekombinante dna-verbindungen und expression von polypeptiden wie tpa. |
IL115420A0 (en) | 1994-09-26 | 1995-12-31 | Zeneca Ltd | Aminoheterocyclic derivatives |
EP1249233B9 (en) | 1999-11-26 | 2009-08-05 | Shionogi & Co., Ltd. | Npyy5 antagonists |
FR2819254B1 (fr) * | 2001-01-08 | 2003-04-18 | Fournier Lab Sa | Nouveaux composes de la n-(phenylsulfonyl) glycine, leur procede de preparation et leur utilisation pour obtenir des compostions pharmaceutiques |
FR2840897B1 (fr) * | 2002-06-14 | 2004-09-10 | Fournier Lab Sa | Nouveaux derives d'arylsulfonamides et leur utilisation en therapeutique |
EP1572678A4 (en) | 2002-12-19 | 2008-05-07 | Elan Pharm Inc | SUBSTITUTED N-PHENYL SULPHONAMIDES ALSBRADYKININ ANTAGONISTS |
CN1756551A (zh) * | 2003-01-31 | 2006-04-05 | 普雷迪克医药品控股公司 | 新型芳基哌嗪基化合物 |
BRPI0408689B8 (pt) | 2003-03-25 | 2021-05-25 | Laboratoires Fournier S A | derivados de benzenosulfonamida, método para preparação e utilização disso para o tratamento da dor |
US7521457B2 (en) | 2004-08-20 | 2009-04-21 | Boehringer Ingelheim International Gmbh | Pyrimidines as PLK inhibitors |
EP1799637A1 (en) * | 2004-09-23 | 2007-06-27 | Amgen, Inc | Substituted sulfonamidopropionamides and methods of use |
US20080090863A1 (en) | 2004-09-30 | 2008-04-17 | Taisho Pharmaceutical Co., Ltd. | Pyridine Derivatives and Their Use as Medicaments for Treating Diseases Related to Mch Receptor |
DE102005013967A1 (de) | 2004-11-05 | 2006-10-05 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Bradykinin-B1-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel |
WO2006071775A2 (en) | 2004-12-29 | 2006-07-06 | Elan Pharmaceuticals, Inc. | Novel compounds useful for bradykinin b1 receptor antagonism |
CA2687931C (en) | 2007-05-31 | 2016-05-24 | Boehringer Ingelheim International Gmbh | Ccr2 receptor antagonists and uses thereof |
DE102007034620A1 (de) | 2007-07-25 | 2009-01-29 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue B1-Antagonisten |
EP2212281B1 (de) | 2007-08-14 | 2011-03-23 | Boehringer Ingelheim International GmbH | Arylsulfonamide mit analgetischer wirkung |
US8394805B2 (en) | 2007-08-14 | 2013-03-12 | Boehringer Ingelheim International Gmbh | Compounds |
DE102007046887A1 (de) | 2007-09-28 | 2009-04-09 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren zur Herstellung von (1R,5S)-Anhydroecgoninestersalzen |
-
2008
- 2008-08-12 US US12/672,460 patent/US8394805B2/en active Active
- 2008-08-12 BR BRPI0815181 patent/BRPI0815181A2/pt not_active Application Discontinuation
- 2008-08-12 MX MX2010001664A patent/MX2010001664A/es active IP Right Grant
- 2008-08-12 CN CN2008801116296A patent/CN101821245B/zh not_active Expired - Fee Related
- 2008-08-12 JP JP2010520555A patent/JP5250627B2/ja active Active
- 2008-08-12 EP EP08803005.1A patent/EP2188269B1/de active Active
- 2008-08-12 CA CA2696261A patent/CA2696261A1/en not_active Abandoned
- 2008-08-12 WO PCT/EP2008/060562 patent/WO2009021944A1/de active Application Filing
- 2008-08-12 AU AU2008288431A patent/AU2008288431A1/en not_active Abandoned
- 2008-08-12 NZ NZ583815A patent/NZ583815A/en not_active IP Right Cessation
- 2008-08-12 EA EA201000296A patent/EA201000296A1/ru unknown
- 2008-08-12 PE PE2008001366A patent/PE20090593A1/es not_active Application Discontinuation
- 2008-08-12 KR KR1020107005536A patent/KR20100055469A/ko not_active Application Discontinuation
- 2008-08-13 TW TW097130828A patent/TW200911744A/zh unknown
- 2008-08-13 UY UY31287A patent/UY31287A1/es not_active Application Discontinuation
- 2008-08-13 AR ARP080103538A patent/AR068341A1/es unknown
-
2009
- 2009-02-13 AU AU2009281472A patent/AU2009281472A1/en not_active Abandoned
-
2010
- 2010-02-12 CO CO10016009A patent/CO6331335A2/es active IP Right Grant
- 2010-02-12 TN TNP2010000072A patent/TN2010000072A1/fr unknown
- 2010-02-15 MA MA32623A patent/MA31613B1/fr unknown
- 2010-02-19 EC EC2010009978A patent/ECSP109978A/es unknown
- 2010-11-22 ZA ZA2010/08350A patent/ZA201008350B/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP5250627B2 (ja) | 2013-07-31 |
MX2010001664A (es) | 2010-03-10 |
TW200911744A (en) | 2009-03-16 |
ECSP109978A (es) | 2010-03-31 |
AU2008288431A1 (en) | 2009-02-19 |
CN101821245A (zh) | 2010-09-01 |
MA31613B1 (fr) | 2010-08-02 |
UY31287A1 (es) | 2009-04-30 |
TN2010000072A1 (en) | 2011-09-26 |
CO6331335A2 (es) | 2011-10-20 |
CA2696261A1 (en) | 2009-02-19 |
JP2010535839A (ja) | 2010-11-25 |
PE20090593A1 (es) | 2009-06-03 |
ZA201008350B (en) | 2011-08-31 |
KR20100055469A (ko) | 2010-05-26 |
AU2009281472A1 (en) | 2010-02-18 |
US20110098282A1 (en) | 2011-04-28 |
CN101821245B (zh) | 2012-10-10 |
WO2009021944A1 (de) | 2009-02-19 |
NZ583815A (en) | 2012-03-30 |
EP2188269B1 (de) | 2014-05-07 |
BRPI0815181A2 (pt) | 2015-03-31 |
AR068341A1 (es) | 2009-11-11 |
EP2188269A1 (de) | 2010-05-26 |
US8394805B2 (en) | 2013-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200900279A1 (ru) | Арилсульфонамиды с аналгетическим действием | |
EA201000296A1 (ru) | Новые соединения | |
EA201201167A1 (ru) | Соединения в качестве антагонистов брадикинина b1 | |
EA200802210A1 (ru) | Замещенные пролинамиды, их получение и их применение в качестве лекарственных средств | |
EA200801998A1 (ru) | ПИРИДИН[3,4-b]ПИРАЗИНОНЫ | |
EA201170772A1 (ru) | Органические соединения | |
EA200900959A1 (ru) | Ингибиторы мек | |
EA201290416A1 (ru) | Новые спиропиперидиновые соединения | |
EA201201662A1 (ru) | Дизамещенные тетрагидрофуранильные соединения в качестве антагонистов брадикининового рецептора в1 | |
EA201100992A1 (ru) | Карбазолкарбоксамидные соединения, применимые в качестве ингибиторов киназы | |
EA200700188A1 (ru) | Производные замещенного 2-алкилхиназолинона как ингибиторы parp | |
EA200700185A1 (ru) | Производные хиназолиндиона в качестве ингибиторов parp | |
EA201101672A1 (ru) | Замещенные производные аминомасляной кислоты в качестве ингибиторов неприлизина | |
EA201000612A1 (ru) | Антагонисты cgrp-пептиды | |
EA200802007A1 (ru) | Соединения, потенцирующие рецептор амра, и применение указанных соединений в медицине | |
EA200970124A1 (ru) | Производные 2-арилиндола в качестве ингибиторов npges-1 | |
EA200900397A1 (ru) | Новые соединения диосметина, способ их получения и фармацевтические композиции, которые их содержат | |
EA200800393A1 (ru) | Новые соединения-аналоги камптотецина, способ их получения и фармацевтические композиции, которые их содержат | |
EA200601845A1 (ru) | НОВЫЕ β-АГОНИСТЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ЛЕКАРСТВЕННЫХ СРЕДСТВ | |
EA201001855A1 (ru) | Соединения, содержащие циклобутоксигруппу | |
SE0402925D0 (sv) | Novel Compounds | |
EA200600760A1 (ru) | Новые соединения фенилпиридилпиперазина, способ их получения и фармацевтические композиции, содержащие их | |
EA200900269A1 (ru) | Лекарственные комбинации для лечения заболеваний дыхательных путей | |
EA201001517A1 (ru) | Замещенные пиперидины в качестве терапевтических соединений | |
EA200701843A1 (ru) | 2-оксо-1,2,4,5-тетрагидро-1,3-бензодиазепин-3-илпиперидины в качестве cgrp-антагонистов |